NCT02813148View on ClinicalTrials.gov

Naloxegol Drug Utilization Post Authorisation Safety Study

CompletedOBSERVATIONAL
Enrollment

17,254

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

January 31, 2020

Conditions
Opioid Induced Constipation
Interventions
DRUG

Naloxegol

Non-interventional study of drug utilization

Trial Locations (4)

Unknown

Research Site, Frankfurt am Main

Research Site, Oslo

Research Site, Mölndal

Research Site, London

Sponsors
All Listed Sponsors
lead

Kyowa Kirin Pharmaceutical Development Ltd

INDUSTRY

NCT02813148 - Naloxegol Drug Utilization Post Authorisation Safety Study | Biotech Hunter | Biotech Hunter